| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.025 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |